SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SP, PCTI, MRTX

NEW YORK, Oct. 31, 2023

SP® Plus Corporation (NASDAQ: SP)'s sale to Metropolis Technologies, Inc. for $54.00 per share in cash. If you are a SP® Plus shareholder, click here to learn more about your rights and options.  

PCTEL, Inc. (NASDAQ: PCTI)'s sale to Amphenol Corporation for $7.00 per share in cash. If you are a PCTEL shareholder, click here to learn more about your rights and options.

Mirati Therapeutics, Inc. (NASDAQ: MRTX)'s sale to Bristol Myers Squibb for $58.00 per share in cash. Additionally, Mirati shareholders will also receive one non-tradeable Contingent Value Right per Mirati share, entitling its holder to receive a one-time potential payment of $12.00 in cash upon acceptance by U.S. FDA of a new drug application for MRTX1719 for the treatment of either locally advanced or metastatic NSCLC in patients who have received no more than two prior lines of systemic therapy within seven years after the closing of the merger. If you are a Mirati shareholder, click here to learn more about your rights and options.

Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.